Ranked #1,816 of 8,699 institutional investors
Broadwood Capital Inc
New York, NY
$1.51B
US stock portfolio at live prices · today −$6.0M (−0.39%)
Live prices, last trade 11:39 AM ET
- Value at quarter end (Q3 2026)
- $1.56B
- Change from Q2 2026
- −$355.8M (−18.60%)
- Positions
- 6 · 0 new, 0 sold out
- Filed
- Nov 16, 2026
Holdings
Q3 2026 13F, live pricesMNST 47.4%STAA 26.2%AXON 14.1%IWM 8.20%LCTX 2.65%
| Stock | Shares | Value, live | % of portfolio | vs Q2 2026 |
|---|---|---|---|---|
| MNST Monster Beverage Corporation | 16,214,968 | $715M | 47.4% | Unchanged |
| STAA STAAR Surgical Company | 16,123,842 | $396M | 26.2% | Unchanged |
| AXON Axon Enterprise, Inc. | 693,504 | $213M | 14.1% | Unchanged |
| IWM iShares Russell 2000 ETF | 474,920 | $124M | 8.20% | Unchanged |
| LCTX Lineage Cell Therapeutics, Inc. | 49,560,992 | $40.0M | 2.65% | Unchanged |
| IMDX Insight Molecular Diagnostics Inc. | 12,684,884 | $22.5M | 1.49% | Unchanged |